NFATC1 and asthma: MiR-143-3p inhibits airway remodeling in asthma, suppressing transforming growth factor (TGF)-β1-induced cell proliferation and protein deposition of extracellular matrix (ECM) production proliferation via negative regulation of nuclear factor of activated T cells 1 (NFATc1) signaling [58].